Literature DB >> 17074595

Myelodysplastic syndrome associated with monosomy 7 in childhood: a retrospective study.

Dilek Aktas1, Ergul Tuncbilek.   

Abstract

Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by ineffective hematopoiesis, peripheral cytopenia, and dysplastic changes in the bone marrow. Monosomy 7 or partial loss of 7q is a common cytogenetic abnormality in MDS patients and is associated with poor prognosis. This study examined eight patients with monosomy 7 and MDS. Five MDS patients with monosomy 7 progressed to acute leukemia: three cases transformed into acute myelogenous leukemia (AML) in a mean time of only 4.6 months and two cases into acute lymphoblastic leukemia (ALL) in a mean time of 9 months. To our knowledge, this is the first report showing progression of monosomy 7 associated with MDS to ALL in the childhood period.

Entities:  

Mesh:

Year:  2006        PMID: 17074595     DOI: 10.1016/j.cancergencyto.2006.06.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Successful cord blood transplantation in a girl with monosomy 7 myelodysplastic syndrome and reduced numbers of B cells.

Authors:  Chien-Chung Lee; Chao-Ping Yang; Ming Horng Tsai; Wen-I Lee; En-Chen Fang; Tang-Her Jaing
Journal:  Int J Hematol       Date:  2010-03-17       Impact factor: 2.490

Review 2.  Current treatment options: impact of cytogenetics on the course of myelodysplasia.

Authors:  Naomi Galili; Jan Cerny; Azra Raza
Journal:  Curr Treat Options Oncol       Date:  2007-04

3.  Specific genomic regions are differentially affected by copy number alterations across distinct cancer types, in aggregated cytogenetic data.

Authors:  Nitin Kumar; Haoyang Cai; Christian von Mering; Michael Baudis
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  Clinical utility of chromosomal microarray analysis in the diagnosis and management of monosomy 7 mosaicism.

Authors:  Alka Chaubey Nee Dwivedi; Michael J Lyons; Kat Kwiatkowski; Frank O Bartel; Michael J Friez; Kenton R Holden; Eric T Fung; Barbara R DuPont
Journal:  Mol Cytogenet       Date:  2014-12-04       Impact factor: 2.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.